Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Prostatic Neoplasms × Carboplatin × Clear all

Phase

Phase 2 25 Phase 1 7 Phase 1/2 4 Phase 3 2 Phase NA 1 Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 9 Ovarian Neoplasms 6 Central Nervous System Neoplasms 5 Retinoblastoma 3 Lung Neoplasms 3 Breast Neoplasms 3 Uterine Cervical Neoplasms 2 Spinal Cord Neoplasms 2 Oligodendroglioma 2 Neuroblastoma 2 Neoplasms 2 Lymphoma 2 Fallopian Tube Neoplasms 2 Brain Neoplasms 2 Adenocarcinoma of Lung 2 Vomiting 1 Triple Negative Breast Neoplasms 1 Testicular Neoplasms 1 Teratoma 1 Stage IA Uterine Sarcoma 1 Solid Tumor Cancer 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Prostatic Neoplasms 1 Ovarian Germ Cell Cancer 1 Osteosarcoma 1 Optic Nerve Glioma 1 Neoplasms, Germ Cell and Embryonal 1

Interventions

Radiosurgery 38 Magnetic Resonance Spectroscopy 33 Radiotherapy 25 Standard of Care 24 Exercise 24 Brachytherapy 19 Early Intervention, Educational 18 Magnetic Resonance Imaging 15 Surveys and Questionnaires 14 Androgen Antagonists 14 Interviews as Topic 13 Blood Specimen Collection 12 Multiparametric Magnetic Resonance Imaging 11 Methods 11 Biopsy 11 Specimen Handling 10 Radiotherapy, Intensity-Modulated 10 Psychiatric Rehabilitation 10 Prostatectomy 9 Educational Status 9 Therapeutics 8 Resistance Training 8 Radiation 7 Practice Guidelines as Topic 7 Diet Therapy 7 Acupuncture Therapy 7 gallium 68 PSMA-11 6 bicalutamide 6 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 6 Proton Therapy 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06864533 2025-04-24

PKUFH-GS5

Peking University First Hospital

Phase NA Recruiting

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡